IL93119A - Intracellular linkage molecule-1 is purified, AND that encodes it, its preparation and pharmaceutical preparations that contain it - Google Patents

Intracellular linkage molecule-1 is purified, AND that encodes it, its preparation and pharmaceutical preparations that contain it

Info

Publication number
IL93119A
IL93119A IL9311990A IL9311990A IL93119A IL 93119 A IL93119 A IL 93119A IL 9311990 A IL9311990 A IL 9311990A IL 9311990 A IL9311990 A IL 9311990A IL 93119 A IL93119 A IL 93119A
Authority
IL
Israel
Prior art keywords
sicam
icam
binding
adhesion molecule
cells
Prior art date
Application number
IL9311990A
Other languages
English (en)
Hebrew (he)
Other versions
IL93119A0 (en
Inventor
Jeffrey Greve
Alan Mcclelland
Original Assignee
Molecular Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26972210&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL93119(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/301,192 external-priority patent/US5235049A/en
Application filed by Molecular Therapeutics Inc filed Critical Molecular Therapeutics Inc
Publication of IL93119A0 publication Critical patent/IL93119A0/xx
Publication of IL93119A publication Critical patent/IL93119A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Bipolar Transistors (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL9311990A 1989-01-24 1990-01-22 Intracellular linkage molecule-1 is purified, AND that encodes it, its preparation and pharmaceutical preparations that contain it IL93119A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/301,192 US5235049A (en) 1989-01-24 1989-01-24 Nucleic acid sequences encoding a soluble molecule (SICAM-1) related to but distinct from ICAM-1
US44595189A 1989-12-13 1989-12-13

Publications (2)

Publication Number Publication Date
IL93119A0 IL93119A0 (en) 1990-11-05
IL93119A true IL93119A (en) 1999-07-14

Family

ID=26972210

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9311990A IL93119A (en) 1989-01-24 1990-01-22 Intracellular linkage molecule-1 is purified, AND that encodes it, its preparation and pharmaceutical preparations that contain it

Country Status (15)

Country Link
EP (1) EP0379904B1 (de)
JP (1) JP3080631B2 (de)
KR (1) KR100202435B1 (de)
AT (1) ATE137799T1 (de)
AU (1) AU641134B2 (de)
DE (1) DE69026844T2 (de)
DK (1) DK0379904T3 (de)
ES (1) ES2087091T3 (de)
FI (1) FI100601B (de)
GR (1) GR3020481T3 (de)
IE (1) IE74144B1 (de)
IL (1) IL93119A (de)
NO (1) NO900155L (de)
NZ (1) NZ232203A (de)
PT (1) PT92920B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143298A (en) * 1988-09-01 2000-11-07 Bayer Corporation Soluble truncated forms of ICAM-1
US6514936B1 (en) 1988-09-01 2003-02-04 Bayer Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)
US6051231A (en) * 1988-09-01 2000-04-18 Bayer Corporation Antiviral methods and prepations
ZA896668B (en) * 1988-09-01 1990-06-27 Molecular Therapeutics Inc A human rhinovirus receptor protein that inhibits virus infectivity
EP0362531B1 (de) 1988-09-01 1999-11-10 Bayer Corporation Menschliches Rhinovirusrezeptorprotein, das die Virusinfektionsanfälligkeit hemmt
US5776775A (en) * 1989-02-21 1998-07-07 Dana-Farber Cancer Institute Anti-LAM 1-3 antibody and hybridoma
US6797270B1 (en) 1989-03-16 2004-09-28 Center For Blood Research, Inc. Functional derivatives of the intercellular adhesion molecule ICAM-1 in anti-viral therapy
DK0745852T3 (da) * 1989-03-16 2002-10-14 Blood Res Center Anvendelse af funktionelle derivater af intercellulær adhæsion-molekylet ICAM-1 i antiviral terapi
HU217792B (hu) * 1989-03-16 2000-04-28 Dana Farber Cancer Institute Eljárás intercelluláris adhéziós molekula (ICAM-1) oldható származékai és ezeket tartalmazó gyógyszerkészítmények előállítására
WO1991018011A1 (en) * 1990-05-15 1991-11-28 Swinburne Limited Inhibition of cell adhesion using intercellular adhesion molecule-1-like peptides and/or analogues thereof
WO1991018010A1 (en) * 1990-05-15 1991-11-28 Swinburne Limited Inhibition of viral infection using intercellular adhesion molecule-1-like peptides and/or analogues thereof
US6130202A (en) * 1990-07-20 2000-10-10 Bayer Corporation Antiviral methods
ATE184049T1 (de) * 1990-07-20 1999-09-15 Bayer Ag Multimere formen des menschlichen rhinovirus- rezeptorproteins
US6107461A (en) * 1990-07-20 2000-08-22 Bayer Corporation Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use
US5686582A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric forms of human rhinovirus receptor protein
US5686581A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric form of human rhinovirus receptor protein
AU710965B2 (en) * 1992-06-22 1999-09-30 Bayer Corporation Multimeric forms of human rhinovirus receptor protein
CA2140933A1 (en) * 1992-08-21 1994-02-22 Paula M. Jardieu Method for treating an lfa-1 mediated disorder
FR2710778B1 (fr) * 1993-09-29 1995-12-01 Framatome Sa Grappe de commande pour réacteur nucléaire et réacteur en faisant application.
DE4335273A1 (de) * 1993-10-15 1995-04-20 Univ Ludwigs Albert Peptide zur Tumortherapie
US20020081294A1 (en) 1996-01-23 2002-06-27 Genentech, Inc. Co-administration of a thrombolytic and an anti-CD18 antibody in stroke
US5914112A (en) * 1996-01-23 1999-06-22 Genentech, Inc. Anti-CD18 antibodies in stroke
AU735917B2 (en) * 1997-10-02 2001-07-19 Icos Corporation ICAM-4 and diagnostic uses thereof
FR2788161B1 (fr) * 1998-12-30 2001-03-23 Framatome Sa Crayon absorbant pour grappe de commande de reacteur nucleaire
US6582698B1 (en) 1999-03-19 2003-06-24 Genentech, Inc. Treatment method
WO2000056363A1 (en) 1999-03-19 2000-09-28 Genentech, Inc. Treatment of lfa-1 associated disorders with increasing doses of lfa-1 antagonist
US8741557B2 (en) 2003-02-14 2014-06-03 Beth Israel Deaconess Medical Center, Inc. Predicting graft rejection
JP4671323B2 (ja) * 2004-04-28 2011-04-13 大日本印刷株式会社 ディスプレイ装置
EP1756163A2 (de) 2004-06-09 2007-02-28 Genentech, Inc. Verfahren zur behandlung von granuloma annulare oder sarkoid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE128727T1 (de) * 1987-05-04 1995-10-15 Dana Farber Cancer Inst Inc Interzellulare adhäsions-moleküle und deren bindungsliganden.
ATE114972T1 (de) * 1987-11-02 1994-12-15 Baylor College Medicine Verwendung von icam-1 oder ihre funktionelle derivate zur behandlung unspezifischer entzündungen.
CA1341055C (en) * 1987-12-08 2000-07-18 Alan Mcclelland Transfectant cell lines which express the major human rhinovirus receptor
EP0362531B1 (de) * 1988-09-01 1999-11-10 Bayer Corporation Menschliches Rhinovirusrezeptorprotein, das die Virusinfektionsanfälligkeit hemmt
AU636230B2 (en) * 1990-10-24 1993-04-22 Dolores Y. Beaupied Garment to hold an ostomy appliance

Also Published As

Publication number Publication date
NZ232203A (en) 1992-10-28
FI900331A0 (fi) 1990-01-22
KR900011895A (ko) 1990-08-02
IE900257L (en) 1990-07-24
KR100202435B1 (ko) 1999-06-15
AU4876790A (en) 1990-08-02
NO900155D0 (no) 1990-01-11
IE74144B1 (en) 1997-07-02
DK0379904T3 (da) 1996-09-16
PT92920A (pt) 1990-07-31
EP0379904A1 (de) 1990-08-01
GR3020481T3 (en) 1996-10-31
NO900155L (no) 1990-07-25
DE69026844D1 (de) 1996-06-13
ATE137799T1 (de) 1996-05-15
EP0379904B1 (de) 1996-05-08
DE69026844T2 (de) 1996-09-12
JP3080631B2 (ja) 2000-08-28
PT92920B (pt) 1995-12-29
ES2087091T3 (es) 1996-07-16
JPH0381296A (ja) 1991-04-05
IL93119A0 (en) 1990-11-05
FI100601B (fi) 1998-01-15
AU641134B2 (en) 1993-09-16

Similar Documents

Publication Publication Date Title
EP0379904B1 (de) Lösliches Molekül, das mit ICAM-1 verwandt, aber davon verschieden ist
US5235049A (en) Nucleic acid sequences encoding a soluble molecule (SICAM-1) related to but distinct from ICAM-1
CA2008368C (en) Soluble molecule related to but distinct from icam-1
Lokeshwar et al. Ankyrin-binding domain of CD44 (GP85) is required for the expression of hyaluronic acid-mediated adhesion function.
US6020188A (en) Polynucleotides encoding platelet endothelial cell adhesion molecule (PECAM-1) and fragments thereof
JP3253064B2 (ja) ウイルスの感染性を阻止するヒトライノウイルス受容体タンパク質
US5316920A (en) Lymphocyte activation antigen HB15, a member of the immunoglobulin superfamily
WO1994027638A1 (en) Monoclonal antibodies that block ligand binding to the cd22 receptor in mature b cells
WO2000008057A2 (en) Molecules designated b7l-1
JP3534406B2 (ja) 免疫グロブリンＥの高アフィニティレセプタのヒトβサブユニットの分離，特性化および用法
WO1994013312A1 (en) Mucosal vascular addressin, dna and expression
WO1992000751A1 (en) A pharmaceutical composition comprising a cell adhesion molecule
Van Noesel et al. Comparison of human B cell antigen receptor complexes: membrane-expressed forms of immunoglobulin (Ig) M, IgD, and IgG are associated with structurally related heterodimers.
AU632513B2 (en) Cdnas coding for the gamma subunit of the high-affinity receptor for immunoglobulin e
CA2119974C (en) Human cell adhesion molecule and nucleic acid sequences
US5917030A (en) Platelet cell adhesion molecule and variants thereof
US6165744A (en) Isolation and characterization of cDNAs coding for the α, β, and γ subunits of the high-affinity receptor for immunoglobulin E
AU639300C (en) A platelet cell adhesion molecule and variants thereof
WO1991013085A1 (en) Mononuclear leukocyte directed endothelial adhesion molecule associated with atherosclerosis
US20100144640A1 (en) Molecules designated b7l-1

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
FF Patent granted
KB Patent renewed
KB Patent renewed
EXP Patent expired